Cidara Therapeutics Inc Share Price

NASDAQ: CDTX

Small Cap

$66.94

+1.32

(+2.01%)

as on September 16, 2025 at 1:29 am IST

$₹

Cidara Therapeutics Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$63.8
Day's Price Range
$67.86
$66.94
4.69%
Downside
1.37%
Upside
52 Week's Low
52 Week's High
$10.14
52-Week Price Range
$69.36
$66.94
84.85%
Downside
3.62%
Upside

Cidara Therapeutics Inc share price movements today

Previous Close: $65.62
Open: $66.59
Volume: 596.3K
Day's Low - High: $63.8 - $67.86
52 Week Low - High: $10.14 - $69.36

Cidara Therapeutics Inc Historical Returns

1 Month Return: + 0.62 %
3 Month Return: + 187.3 %
1 Year Return: + 449.58 %
3 Year Return: + 354.87 %
5 Year Return: + 0.34 %

Cidara Therapeutics Inc Stock Fundamentals & Key Indicators

Check Cidara Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-6.015

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.8

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-133.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

27059400.00%

Cidara Therapeutics Inc Stock Valuation

Track how Cidara Therapeutics Inc P/E has moved over time to understand its valuation trends.

Cidara Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 15, 2025

Industry (0.00x)

September 15, 2025

Today (-0.80x)

September 15, 2025

Highest (-0.48x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.80x

Cidara Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cidara Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cidara Therapeutics Inc	BUY	$1.7B	0.34%	-0.8	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Cidara Therapeutics Inc Stock including INR - Dollar returns

The Cidara Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cidara Therapeutics Inc investment value today

Current value as on today

₹5,65,622

Returns

₹4,65,622

(+465.62%)

Returns from Cidara Therapeutics Inc Stock

₹4,60,637 (+460.64%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Cidara Therapeutics Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Cidara Therapeutics Inc. Average target price of $79.8

Cidara Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Cidara Therapeutics Inc.

What analysts predicted

16.12%UPSIDE

Target Price

$79.8

Current Price

$66.94

Analyzed by

10 Analysts

Target

$79.80

Cidara Therapeutics Inc target price $79.8, a slight upside of 16.12% compared to current price of $66.94. According to 10 analysts rating.

Cidara Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Cidara Therapeutics Inc Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:10% versus previous 30 day period

Cidara Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	26	7	12	17	8	0	-	-	-	-
Gross Profit	26	7	12	16	6	0	0	-90	0	0
Operating Income	2	-12	-4	-6	-10	-11	-17	-54	-25	-31
EBITDA	2	-6	-3	-	-10	-11	-17	-54	-25	-27
Interest Expense	0	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	3	-12	-3	-5	-10	-94	-15	-52	-23	-25
Income Tax Expense	0	0	0	-	0	-4	-	-	-	-
Net Income	3	-12	-8	-5	-10	-89	-15	-52	-23	-25
Net Profit Margin	11.54%	-162.29%	-64.26%	-31.91%	-122.01%	-29605.96%	0.00%	0.00%	0.00%	0.00%

Cidara Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	20	12	49	64	63	1
Gross Profit	0	0	-42	0	-25	-55	49	64	62	-83
Operating Income	-32	-48	-55	-63	-41	-71	-42	-29	-24	-176
EBITDA	-31	-47	-55	-62	-41	-71	-43	-28	-24	-176
Interest Expense	0	0	0	0	0	0	0	0	-	-
Depreciation	-	-	0	0	0	0	-1	1	0	0
Income Before Tax	-32	-48	-55	-59	-41	-72	-42	-29	-22	-170
Income Tax Expense	0	0	0	4	-1	0	1	0	0	-
Net Income	-32	-48	-55	-59	-41	-72	-43	-29	-22	-169
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-196.47%	-599.76%	-88.58%	-46.35%	-35.88%	-13319.76%

Cidara Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-12	-8	-3	-10	-89	-12	-52	-23	-25
Operating Cash Flow	2	-1	-12	-6	-103	-36	-29	-21	-40
Investing Cash Flow	0	0	-	0	-	0	-	0	-
Financing Cash Flow	0	8	0	0	239	0	98	0	383
Change in Cash	2	-1	-12	-6	135	-36	68	-21	342

Cidara Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-48	-55	-59	-41	-72	-42	-29	-22	-169
Operating Cash Flow	-39	-49	-56	-28	-54	-25	-28	-22	-176
Investing Cash Flow	25	4	14	0	0	0	0	0	0
Financing Cash Flow	37	20	56	14	37	44	0	25	337
Change in Cash	22	-24	13	-14	-17	19	-29	3	160

Global Institutional Holdings in Cidara Therapeutics Inc

Funds	Holdings
RA Capital Management, LLC	4.94%
VR Adviser, LLC	4.75%
TCG Crossover Management, LLC	4.55%
Adage Capital Partners Gp LLC	4.48%
Bvf Inc	4.18%

See all

Insights on Cidara Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, CDTX stock has moved up by 187.3%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CDTX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, CDTX has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 17.58M → 302.0K (in $), with an average decrease of 74.2% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -23.48M → -25.71M (in $), with an average decrease of 9.5% per quarter

About Cidara Therapeutics Inc

cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies. our first product candidate is cd101 iv, a potential once-weekly intravenous therapy being developed for the treatment and prevention of systemic fungal infections. our second product candidate, cd101 topical, is a topical formulation of cd101, the first topical application of the enchinocandin class of anti-fungals, for the treatment of vulvovaginal candidiasis, or vvc. in addition, we have developed a proprietary immunotherapy technology platform, cloudbreak™, which we use to create compounds designed to direct a patient’s immune cells to attack and eliminate pathogens that cause infectious disease. we are developing our first cloudbreak development candidate, c001, for the treatment of invasive aspergillosis.

Organisation	Cidara Therapeutics Inc
Headquarters	6310 Nancy Ridge Drive, San Diego, CA, United States, 92121
Industry	Health Technology
CEO	Dr. Jeffrey L. Stein Ph.D.
E-voting on shares	Click here to vote

Key Management of Cidara Therapeutics Inc

Name	Title
Ms. Corrina Pavetto	Senior Vice President of Clinical Development
Dr. Kevin M. Forrest Ph.D.	Founder & Chief Strategy Officer
Mr. Frank L. Karbe M.B.A.	Chief Financial Officer
Dr. Preetam Shah M.B.A., Ph.D.	Principal Accounting Officer
Dr. Nicole Davarpanah J.D., M.D.	Chief Medical Officer
Mr. Jim Beitel M.B.A.	Chief Business Officer
Dr. Jeffrey L. Stein Ph.D.	President, CEO & Executive Director
Dr. Leslie Tari Ph.D.	Chief Scientific Officer
Mr. Shane M. Ward J.D.	COO & Corporate Secretary
Ms. Allison Lewis CCP, SPHR	Senior Vice President of People & Culture

FAQs

What is Cidara Therapeutics Inc share price today?

Cidara Therapeutics Inc share price today is $66.94 as on September 16, 2025 at 1:29 am IST at the close of the market. Cidara Therapeutics Inc share today touched a day high of $67.86 and a low of $63.8.

What is the 52 week high and 52 week low for Cidara Therapeutics Inc share?

Cidara Therapeutics Inc share touched a 52 week high of $69.36 on August 21, 2025 and a 52 week low of $10.14 on October 15, 2024. Cidara Therapeutics Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $66.94,which is 3.49% down from its 52 week high and 560.16% up from its 52 week low.

What is Cidara Therapeutics Inc's market capitalisation today?

Cidara Therapeutics Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Cidara Therapeutics Inc Stock (CDTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cidara Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cidara Therapeutics Inc Shares that will get you 0.0224 shares as per Cidara Therapeutics Inc share price of $66.94 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cidara Therapeutics Inc Stock (CDTX) from India?

Indian investors can start investing in Cidara Therapeutics Inc (CDTX) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 2:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Cidara Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 2:39 am IST). Based on Cidara Therapeutics Inc share’s latest price of $66.94 as on September 16, 2025 at 1:29 am IST, you will get 0.1494 shares of Cidara Therapeutics Inc. Learn more about fractional shares .

What are the returns that Cidara Therapeutics Inc has given to Indian investors in the last 5 years?

Cidara Therapeutics Inc stock has given 0.34% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?